Regulatory changes to the nursing home industry for this year may seem small individually, but together, they reflect broader initiatives sought by the ...

A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...

Trial investigates macrophage re-reprogramming immunotherapy bexmarilimab in combination with azacitidine to prevent relapse in MRD-positive AML after stem cell transplantation. TURKU, FI / ACCESS New ...

Building closer relationships with facility staff and health care partners of nursings homes, such as hospital providers and pharmacies, is going to be ...

CareDx CDNA recently announced clinical validation data supporting AlloHeme, its next-generation, blood-based monitoring test designed to predict relapses in patients with acute myeloid leukemia (AML) ...

A major study led by the University of Hertfordshire has shown how linking care home data with NHS and social care records can improve residents' lives, strengthen policy decision-making and ensure ...

Poster to be presented at Tandem Meeting of the American Society of Transplantation and Cellular Therapy (ASTCT) and the Center for International ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

Experts at a roundtable in Boston, Massachusetts, on November 19, 2025, discussed multidisciplinary strategies for obesity ...

Robust SENTI-202 clinical data presented at ASH 2025 demonstrated deep, MRD-negative, durable complete remissions and a favorable safety ...

Adtalem Global Education changed its name to Covista last week, a move the company says signals its ambitions in addressing ...

UHS moved from Chenango Bridge Road to Upper Front Street to expand access to care for residents in the Southern Tier.